Health Business Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Health Business Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Aetna
Aetna Tackles Quality Issues in Genetic Testing for Breast Cancer
November 21st, 2008
Aetna (NYSE:AET) is implementing a comprehensive plan to increase the quality of genetic diagnosis and treatment of breast cancer. The company is guiding members and physicians to laboratories that meet national guidelines for genetic testing accuracy. Aetna also is funding research to understand the use of genetic tests in breast cancer treatment. Each is an important step to help patients access effective genetic services at each step of their care, and build on Aetna's confidential telephone and Web-based counseling program for members. Approximately 20 percent of people with breast cancer have tumor types with increased levels of the HER2 protein. Accurately...
Source: Health Business Week (2008-11-21)
|
